Adverse events132

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 132

Type	Event	Organ system	Group	Affected	At risk	Events
other	Hypertension	Vascular disorders	Farletuzumab 62.5 mg/m^2	0	2	0
other	Hypertension	Vascular disorders	Farletuzumab 100 mg/m^2	1	1	5
other	Hypotension	Vascular disorders	Farletuzumab 62.5 mg/m^2	0	2	0
other	Hypotension	Vascular disorders	Farletuzumab 100 mg/m^2	1	1	1
other	Tooth extraction	Surgical and medical procedures	Farletuzumab 62.5 mg/m^2	1	2	1
other	Tooth extraction	Surgical and medical procedures	Farletuzumab 100 mg/m^2	0	1	0
other	Fatigue	General disorders	Farletuzumab 62.5 mg/m^2	1	2	2
other	Fatigue	General disorders	Farletuzumab 100 mg/m^2	1	1	11
other	Asthenia	General disorders	Farletuzumab 62.5 mg/m^2	1	2	1
other	Asthenia	General disorders	Farletuzumab 100 mg/m^2	0	1	0
other	Local swelling	General disorders	Farletuzumab 62.5 mg/m^2	1	2	1
other	Local swelling	General disorders	Farletuzumab 100 mg/m^2	0	1	0
other	Oedema peripheral	General disorders	Farletuzumab 62.5 mg/m^2	0	2	0
other	Oedema peripheral	General disorders	Farletuzumab 100 mg/m^2	1	1	4
other	Procedural pain	Injury, poisoning and procedural complications	Farletuzumab 62.5 mg/m^2	0	2	0
other	Procedural pain	Injury, poisoning and procedural complications	Farletuzumab 100 mg/m^2	1	1	4
other	Traumatic haematoma	Injury, poisoning and procedural complications	Farletuzumab 62.5 mg/m^2	0	2	0
other	Traumatic haematoma	Injury, poisoning and procedural complications	Farletuzumab 100 mg/m^2	1	1	1
other	Blood alkaline phosphatase increased	Investigations	Farletuzumab 62.5 mg/m^2	1	2	2
other	Blood alkaline phosphatase increased	Investigations	Farletuzumab 100 mg/m^2	0	1	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01018563/events